|
| 37967307 | Blinatumomab for First-Line Treatment of Children and Young Persons With B-ALL. | J Clin Oncol | 2024 |
| 36332176 | EBV-driven lymphoid neoplasms associated with pediatric ALL maintenance therapy. | Blood | 2023 |
| 37715172 | Targeting WEE1 kinase as a p53-independent therapeutic strategy in high-risk and relapsed acute lymphoblastic leukemia. | Cancer Cell Int | 2023 |
| 37487146 | Outcome for Children and Young Adults With T-Cell ALL and Induction Failure in Contemporary Trials. | J Clin Oncol | 2023 |
| 37824845 | Cranial radiotherapy has minimal benefit in children with central nervous system involvement in T-ALL. | Blood Adv | 2023 |
| 37773265 | Real-world evaluation of UK high hyperdiploidy profile using a large cohort of patients provided by HARMONY data platform. | Leukemia | 2023 |
| 35484682 | Molecular characterization and clinical outcome of B-cell precursor acute lymphoblastic leukemia with IG-MYC rearrangement. | Haematologica | 2023 |
| 37216686 | The genomic landscape of acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21. | Blood | 2023 |
| 37153875 | The Prognostic Effect of <i>IKZF1</i> Deletions in <i>ETV6</i>::<i>RUNX1</i> and High Hyperdiploid Childhood Acute Lymphoblastic Leukemia. | Hemasphere | 2023 |
| 37407142 | Dasatinib with intensive chemotherapy in de novo paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (CA180-372/COG AALL1122): a single-arm, multicentre, phase 2 trial. | Lancet Haematol | 2023 |
| 37098241 | The Clinicogenomic Landscape of Induction Failure in Childhood and Young Adult T-Cell Acute Lymphoblastic Leukemia. | J Clin Oncol | 2023 |
| 36550215 | Integrative genomic analysis of childhood acute lymphoblastic leukaemia lacking a genetic biomarker in the UKALL2003 clinical trial. | Leukemia | 2023 |
| 36670235 | Disruption to the FOXO-PRDM1 axis resulting from deletions of chromosome 6 in acute lymphoblastic leukaemia. | Leukemia | 2023 |
| 36658389 | Whole genome sequencing provides comprehensive genetic testing in childhood B-cell acute lymphoblastic leukaemia. | Leukemia | 2023 |
| 36309560 | Clinical characteristics and outcomes of B-cell precursor ALL with MEF2D rearrangements: a retrospective study by the Ponte di Legno Childhood ALL Working Group. | Leukemia | 2023 |
| 36272172 | Detection of constitutional mismatch repair deficiency in children and adolescents with acute lymphoblastic leukemia. | Leuk Lymphoma | 2023 |
| 34175901 | DNA-thioguanine concentration and relapse risk in children and young adults with acute lymphoblastic leukemia: an IPD meta-analysis. | Leukemia | 2022 |
| 35348200 | Activity and toxicity of intramuscular 1000 iu/m<sup>2</sup> polyethylene glycol-E. coli L-asparaginase in the UKALL 2003 and UKALL 2011 clinical trials. | Br J Haematol | 2022 |
| 35358442 | In-vivo T-cell depleted reduced-intensity conditioned allogeneic haematopoietic stem-cell transplantation for patients with acute lymphoblastic leukaemia in first remission: results from the prospective, single-arm evaluation of the UKALL14 trial. | Lancet Haematol | 2022 |
| 35358441 | Addition of four doses of rituximab to standard induction chemotherapy in adult patients with precursor B-cell acute lymphoblastic leukaemia (UKALL14): a phase 3, multicentre, randomised controlled trial. | Lancet Haematol | 2022 |
| 35714315 | Time to Cure for Childhood and Young Adult Acute Lymphoblastic Leukemia Is Independent of Early Risk Factors: Long-Term Follow-Up of the UKALL2003 Trial. | J Clin Oncol | 2022 |
| 35977468 | hiPSC-derived bone marrow milieu identifies a clinically actionable driver of niche-mediated treatment resistance in leukemia. | Cell Rep Med | 2022 |
| 34788984 | Genetic and genomic analysis of acute lymphoblastic leukemia in older adults reveals a distinct profile of abnormalities: analysis of 210 patients from the UKALL14 and UKALL60+ clinical trials. | Haematologica | 2022 |
| 34657128 | Prognostic impact of chromosomal abnormalities and copy number alterations in adult B-cell precursor acute lymphoblastic leukaemia: a UKALL14 study. | Leukemia | 2022 |
| 34597466 | Clonal dynamics in pediatric B-cell precursor acute lymphoblastic leukemia with very early relapse. | Pediatr Blood Cancer | 2022 |
| 34535761 | DNA-TG and risk of sinusoidal obstruction syndrome in childhood acute lymphoblastic leukemia. | Leukemia | 2022 |
| 34676543 | Genetic characterisation of childhood B-other-acute lymphoblastic leukaemia in UK patients by fluorescence in situ hybridisation and Multiplex Ligation-dependent Probe Amplification. | Br J Haematol | 2022 |
| 34183766 | Prognostic value of Oncogenetic mutations in pediatric T Acute Lymphoblastic Leukemia: a comparison of UKALL2003 and FRALLE2000T protocols. | Leukemia | 2022 |
| 33357483 | Outcomes of paediatric patients with B-cell acute lymphocytic leukaemia with ABL-class fusion in the pre-tyrosine-kinase inhibitor era: a multicentre, retrospective, cohort study. | Lancet Haematol | 2021 |
| 33626861 | The <i>EBF1-PDGFRB</i> T681I mutation is highly resistant to imatinib and dasatinib <i>in vitro</i> and detectable in clinical samples prior to treatment. | Haematologica | 2021 |
| 33895809 | Molecular classification improves risk assessment in adult BCR-ABL1-negative B-ALL. | Blood | 2021 |
| 33692463 | Clinical characteristics and outcomes of B-ALL with ZNF384 rearrangements: a retrospective analysis by the Ponte di Legno Childhood ALL Working Group. | Leukemia | 2021 |
| 35008684 | Genetic Profiles and Risk Stratification in Adult De Novo Acute Myeloid Leukaemia in Relation to Age, Gender, and Ethnicity: A Study from Malaysia. | Int J Mol Sci | 2021 |
| 34715050 | Defining low-risk high hyperdiploidy in patients with paediatric acute lymphoblastic leukaemia: a retrospective analysis of data from the UKALL97/99 and UKALL2003 clinical trials. | Lancet Haematol | 2021 |
| 34477813 | IKZF1 alterations are not associated with outcome in 498 adults with B-precursor ALL enrolled in the UKALL14 trial. | Blood Adv | 2021 |
| 34560013 | Minimal residual disease, long-term outcome, and IKZF1 deletions in children and adolescents with Down syndrome and acute lymphocytic leukaemia: a matched cohort study. | Lancet Haematol | 2021 |
| 33938069 | Single nucleotide polymorphism array-based signature of low hypodiploidy in acute lymphoblastic leukemia. | Genes Chromosomes Cancer | 2021 |
| 34010787 | Risk factors and outcomes in children with high-risk B-cell precursor and T-cell relapsed acute lymphoblastic leukaemia: combined analysis of ALLR3 and ALL-REZ BFM 2002 clinical trials. | Eur J Cancer | 2021 |
| 33197935 | SSBP2-CSF1R is a recurrent fusion in B-lineage acute lymphoblastic leukemia with diverse genetic presentation and variable outcome. | Blood | 2021 |
| 32315382 | A validated novel continuous prognostic index to deliver stratified medicine in pediatric acute lymphoblastic leukemia. | Blood | 2020 |
| 32084258 | Germline variants in predisposition genes in children with Down syndrome and acute lymphoblastic leukemia. | Blood Adv | 2020 |
| 31821407 | IKZF1 deletions in pediatric acute lymphoblastic leukemia: still a poor prognostic marker? | Blood | 2020 |
| 31913349 | Concordance of copy number abnormality detection using SNP arrays and Multiplex Ligation-dependent Probe Amplification (MLPA) in acute lymphoblastic leukaemia. | Sci Rep | 2020 |
| 32805067 | Challenges of starting treatment protocols for acute lymphoblastic leukaemia in a low-income setting - the Blantyre experience. | Br J Haematol | 2020 |
| 32926422 | Adjuvant tyrosine kinase inhibitor therapy improves outcome for children and adolescents with acute lymphoblastic leukaemia who have an ABL-class fusion. | Br J Haematol | 2020 |
| 29468646 | Early morphological response is significantly associated with, but does not accurately predict, relapse in teenagers and young adults aged 10-24Â years with acute lymphoblastic leukaemia (ALL): results from UKALL2003. | Br J Haematol | 2019 |
| 31767839 | Identification of four novel associations for B-cell acute lymphoblastic leukaemia risk. | Nat Commun | 2019 |
| 29930300 | The ribosomal RPL10 R98S mutation drives IRES-dependent BCL-2 translation in T-ALL. | Leukemia | 2019 |
| 31228194 | A fully computational and reasonable representation for karyotypes. | Bioinformatics | 2019 |
| 30826273 | Outcomes of patients with childhood B-cell precursor acute lymphoblastic leukaemia with late bone marrow relapses: long-term follow-up of the ALLR3 open-label randomised trial. | Lancet Haematol | 2019 |